FDA Approves Targeted COVID Booster with Priority Distribution Plan
FDA approves 2025-2026 COVID boosters targeting JN.1 LP.8.1 variant with restricted access to priority groups including elderly, immunocompromised, and those with underlying...
In health, Informed Clearly decodes fast-moving headlines into clear signal, strategic context, and practical consequences.
301 results • page 16 / 51
FDA approves 2025-2026 COVID boosters targeting JN.1 LP.8.1 variant with restricted access to priority groups including elderly, immunocompromised, and those with underlying...
New research shows tropical regions face increasing zoonotic disease risks due to environmental changes. Experts call for better surveillance, land use policies, and One Health...
The 2025 WHO Pandemic Agreement establishes historic vaccine technology transfer obligations, creating regional production hubs and shifting from charity-based to...
Europe's flu season started four weeks early due to a new H3N2 variant (subclade K), straining healthcare systems. Vaccines remain effective against severe disease despite the...
Schools are expanding mental health services through telehealth integration and workforce recruitment to address the youth mental health crisis, with new federal funding and...
Recent FDA approvals of gene therapies like Beqvez and Kebilidi have sparked debates about million-dollar pricing and equitable access. Payers implement restrictive policies...